Press coverage about Imprivata (NYSE:IMPR) has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Imprivata earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news stories about the technology company an impact score of 44.7549507420936 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Shares of Imprivata (NYSE:IMPR) opened at 19.26 on Friday. Imprivata has a one year low of $10.81 and a one year high of $19.28. The company has a 50-day moving average of $19.26 and a 200-day moving average of $19.25.

COPYRIGHT VIOLATION NOTICE: “Imprivata (NYSE:IMPR) Receiving Somewhat Favorable News Coverage, Analysis Shows” was reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/08/11/imprivata-nyseimpr-receiving-somewhat-favorable-news-coverage-analysis-shows.html.

Imprivata Company Profile

Imprivata, Inc (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure.

Insider Buying and Selling by Quarter for Imprivata (NYSE:IMPR)

Receive News & Ratings for Imprivata Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imprivata Inc and related companies with MarketBeat.com's FREE daily email newsletter.